Correlation Between ATT and Ventana Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ATT and Ventana Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Ventana Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Ventana Biotech, you can compare the effects of market volatilities on ATT and Ventana Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Ventana Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Ventana Biotech.

Diversification Opportunities for ATT and Ventana Biotech

-0.64
  Correlation Coefficient

Excellent diversification

The 3 months correlation between ATT and Ventana is -0.64. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Ventana Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventana Biotech and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Ventana Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventana Biotech has no effect on the direction of ATT i.e., ATT and Ventana Biotech go up and down completely randomly.

Pair Corralation between ATT and Ventana Biotech

Taking into account the 90-day investment horizon ATT Inc is expected to generate 0.09 times more return on investment than Ventana Biotech. However, ATT Inc is 11.72 times less risky than Ventana Biotech. It trades about 0.26 of its potential returns per unit of risk. Ventana Biotech is currently generating about -0.21 per unit of risk. If you would invest  2,183  in ATT Inc on August 26, 2024 and sell it today you would earn a total of  135.00  from holding ATT Inc or generate 6.18% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

ATT Inc  vs.  Ventana Biotech

 Performance 
       Timeline  
ATT Inc 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in ATT Inc are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, ATT unveiled solid returns over the last few months and may actually be approaching a breakup point.
Ventana Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
OK
Over the last 90 days Ventana Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat weak basic indicators, Ventana Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

ATT and Ventana Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ATT and Ventana Biotech

The main advantage of trading using opposite ATT and Ventana Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Ventana Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventana Biotech will offset losses from the drop in Ventana Biotech's long position.
The idea behind ATT Inc and Ventana Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Other Complementary Tools

Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Money Managers
Screen money managers from public funds and ETFs managed around the world
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets